Related Publications

This page lists all work completed as a result of involvement in the TCGA although not necessarily supported by it.

2011

  1. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. “GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.” Genome Biology (2011) 12(4):R41. [PMID: 21527027 ] [Free: BMC]
  2. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva R, Pflueger D, Sougnez C, Onofrio R, Carter SL, Park K, Habegger L, Ambrogio L, Fennell T, Parkin M, Saksena G, Voet D, Ramos AH, Pugh TJ, Wilkinson J, Fisher S, Winckler W, Mahan S, Ardlie K, Baldwin J, Simons JW, Kitabayashi N, MacDonald TY, Kantoff PW, Chin L, Gabriel SB, Gerstein MB, Golub TR, Meyerson M, Tewari A, Lander ES, Getz G, Rubin MA, Garraway LA. “The genomic complexity of primary human prostate cancer.” Nature (2010) 470(7333):214-20. [PMID: 21307934] [Free: NA]
  3. Wagle N, Emery C, Berger MF, Davis MJ, Sawyer A, Pochanard P, Kehoe SM, Johannessen CM, Macconaill LE, Hahn WC, Meyerson M, Garraway LA. “Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling.” J of Clinical Oncology (2011) 29(22):3085-96. [PMID: 21383288] [Free: NA]
  4. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, Anderson KC, Ardlie KG, Auclair D, Baker A, Bergsagel PL, Bernstein BE, Drier Y, Fonseca R, Gabriel SB, Hofmeister CC, Jagannath S, Jakubowiak AJ, Krishnan A, Levy J, Liefeld T, Lonial S, Mahan S, Mfuko B, Monti S, Perkins LM, Onofrio R, Pugh TJ, Rajkumar SV, Ramos AH, Siegel DS, Sivachenko A, Stewart AK, Trudel S, Vij R, Voet D, Winckler W, Zimmerman T, Carpten J, Trent J, Hahn WC, Garraway LA, Meyerson M, Lander ES, Getz G, Golub TR. “Initial genome sequencing and analysis of multiple myeloma.” Nature (2011) 471(7339):467-72. [PMID: 21430775] [Free: NA]

2010

  1. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S. “Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.” Nature Genetics (2010) 42:715-721. [PMID: 20601955] [Free: PubMed]
  2. Scheble VJ, Braun M, Beroukhim R, Mermel CH, Ruiz C, Wilbertz T, Stiedl AC, Petersen K, Reischl M, Kuefer R, Schilling D, Fend F, Kristiansen G, Meyerson M, Rubin MA, Bubendorf L, Perner S. “ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.” Modern Pathology (2010) 23:1061-1067. [PMID: 20473283] [Free: Nature]
  3. Meyerson M, Gbriel S, Getz G. “Advances in understanding cancer genomes through second-generation sequencing.” Nature Reviews Genetics (2010) 11:685-696. [PMID: 20847746] [Free: NA]
  4. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ. “Recurrent BRAF mutations in Langerhans cell histiocytosis.” Blood (2010) 116(11):1919-23. [PMID: 20519626] [Free: NA]
  5. Francis J, Lin W, Rozenblatt-Rosen O, Meyerson M. “The menin tumor suppressor protein is phosphorylated in response to DNA damage.” PLoS One (2010) 6(1):e16119. [PMID: 21264250] [Free: PLoS]
  6. Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, Fend F, Staebler A, Bass AJ, Meyerson M, Rubin MA, Soltermann A, Lengerke C, Perner S. “SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.” Modern Pathology (2010) 24(7):944-53. [PMID: 21460799] [Free: NA]
  7. Tamayo P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N, Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP. “Predicting relapse in patients with medulloblastoma by integrating evidence from
    clinical and genomic features.” J of Clinical Oncology (2010) 29(11):1415-23. [PMID: 21357789] [Free: NA]
  8. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O’Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN; The Cancer Genome Atlas Research Network. “Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.” Cancer Cell (2010) 17(1):98-110. [PMID: 20129251] [Free: PubMed]

Leave a Reply